Static Chart CEL-SCI Corporation

Equities

Market Closed - Nyse Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
1.23 ^USD	-3.15%		-3.15%	-54.78%

May. 08	Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine	MT
May. 08	CEL-SCI Corporation Announces Significantly Positive Outcome from its Recent Meeting with U.S. Food and Drug Administration Regarding Path to Approval for its First-Line Investigational Cancer Immunotherapy Multikine	CI

Duration

Period